Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo

被引:81
|
作者
Nakamura, M
Ofuji, K
Chikama, T
Nishida, T
机构
[1] YAMAGUCHI UNIV,SCH MED,DEPT OPHTHALMOL,UBE,YAMAGUCHI 755,JAPAN
[2] SANTEN PHARMACEUT CO LTD,NARA RES & DEV CTR,NARA,JAPAN
关键词
substance P; insulin-like growth factor-1; corneal wound healing; epithelium; rabbit;
D O I
10.1076/ceyr.16.3.275.15409
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. We investigated the combined effects of substance P (SP) and insulin-like growth factor-1 (IGF-1) on corneal epithelial wound closure in vivo. Methods. The corneal epithelium of 16 rabbits was debrided by n-heptyl alcohol treatment; SP (1 mg/ml) and/or IGF-1 (1 mu g/ml) in phosphate-buffered saline (PBS) were administered immediately and at 2, 3, 6, 8, 10, 24, 26, 28, 30, 32, and 34 hours after debridement. Controls received PBS alone. The eyes were stained with fluorescein and photographed at baseline and at 6, 12, 18, 24, 30, 36, and 38 hours after debridement. The wound radii of the epithelial defects were recorded from hour 12 to hour 30, and the rate of healing was calculated by linear regression analysis. Results. The mean (+/- SD) healing rate in the control group was 57.03 +/- 7.88 mu m/h. The administration of SP or IGF-1 alone did not affect the healing rates, which were 55.49 +/- 2.49 and 55.57 +/- 7.14 mu m/hr, respectively. However, when SP and IGF-1 were combined, the mean healing rate was significantly higher (75.16 +/- 6.68 mu m/hr) than that of the control, SP-treated, or IGF-1-treated groups (p < 0.05). Conclusions. These results demonstrated that SP and IGF-1 synergistically affect corneal epithelial wound closure.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 50 条
  • [41] Nutrient regulation of insulin-like growth factor-1
    Rabkin, R
    MINERAL AND ELECTROLYTE METABOLISM, 1997, 23 (3-6) : 157 - 160
  • [42] Promotive effect of insulin-like growth factor-1 for epithelial sealing to titanium implants
    Atsuta, Ikiru
    Ayukawa, Yasunori
    Furuhashi, Akihiro
    Yamaza, Takayoshi
    Tsukiyama, Yoshihiro
    Koyano, Kiyoshi
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2013, 101 (10) : 2896 - 2904
  • [43] Decrease in Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-1 Ratio in the First Week of Stroke Is Related to Positive Outcomes
    Mattlage, Anna E.
    Rippee, Michael A.
    Sandt, Janice
    Billinger, Sandra A.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (07): : 1800 - 1806
  • [44] Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
    Kasprzak, Aldona
    Adamek, Agnieszka
    Przybyszewska, Wieslawa
    Pyda, Przemyslaw
    Szmeja, Jacek
    Seraszek-Jaros, Agnieszka
    Lanzafame, Agata
    Surdacka, Anna
    Mozer-Lisewska, Iwona
    Koczorowska, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3867 - 3875
  • [45] Alterations in the corneal nerve in type 2 diabetes: preventive effects of insulin-like growth factor-1 treatment
    Ueno, Hiroki
    Hattori, Takaaki
    Kumagai, Yuta
    Suzuki, Noboru
    Ueno, Satoki
    Takagi, Hitoshi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [46] The Effects of Insulin-Like Growth Factor-1 Gene Therapy and Cell Transplantation on Rat Acute Wound Model
    Amiri, Fereshteh Talebpour
    Fathabadi, Fatemeh Fadaei
    Rad, Mahnaz Mahmoudi
    Piryae, Abbas
    Ghasemi, Azar
    Khalilian, Alireza
    Yeganeh, Farshid
    Mosaffa, Nariman
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (10)
  • [47] Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo
    de Ostrovich, Krisztina Kovacs
    Lambertz, Isabel
    Colby, Jennifer K. L.
    Tian, Jie
    Rundhaug, Joyce E.
    Johnston, Dennis
    Conti, Claudio J.
    DiGiovanni, John
    Fuchs-Young, Robin
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (03): : 824 - 834
  • [48] Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice
    Bhat, RV
    Engber, TM
    Zhu, Y
    Miller, MS
    Contreras, PC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (01): : 522 - 530
  • [49] The expression of insulin-like growth factor-1 during adipogenesis in vivo:: Effect of thyroxine
    Kim, HS
    Richardson, RL
    Hausman, GJ
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1998, 112 (01) : 38 - 45
  • [50] Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes
    Brown-Borg, HM
    Rakoczy, SG
    Romanick, MA
    Kennedy, MA
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (02) : 94 - 104